{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T08:25:02Z","timestamp":1787214302698,"version":"build-2736575974"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Sepsis-induced cardiomyopathy (SIC) is an acute reversible myocardial dysfunction complicating sepsis. With impaired cardiac systolic and diastolic function, it greatly increases the risk of multiple organ failure and mortality in septic patients. This systematic review outlines the overall research landscape of SIC, including pathological mechanisms, epidemiological profiles, updated diagnostic systems and innovative therapeutic strategies, as well as existing challenges and future research priorities. Five major pathological pathways jointly mediate SIC progression, and its prevalence and mortality differ substantially across regions, populations and infectious pathogens. The diagnostic framework has been updated to a multi-dimensional evaluation system, and emerging imaging techniques and combined biomarker panels have greatly improved early diagnostic performance. Therapeutic concepts have transformed from conventional symptomatic care to mechanism-oriented precise intervention, with multiple new therapies and intelligent medical tools applied clinically. At present, inconsistent diagnostic criteria, insufficient specific medications and unbalanced medical resources worldwide hinder clinical management. Future studies aim to standardize diagnostic criteria, explore molecular mechanisms, accelerate the clinical application of targeted drugs, and popularize advanced technologies in under-resourced areas to improve patient outcomes.<\/jats:p>","DOI":"10.3389\/fcvm.2026.1825255","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T08:04:20Z","timestamp":1787213060000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Frontiers in the diagnosis and treatment of sepsis-induced cardiomyopathy: current status and prospects"],"prefix":"10.3389","volume":"13","author":[{"given":"Nai","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Emergency, Jiangxi Province Hospital of Integrated Chinese and Western Medicine","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neng","family":"Wang","sequence":"additional","affiliation":[{"name":"Graduate School, Jiangxi University of Chinese Medicine","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"He","sequence":"additional","affiliation":[{"name":"Graduate School, Jiangxi University of Chinese Medicine","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Emergency, Jiangxi Province Hospital of Integrated Chinese and Western Medicine","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B2","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00204-024-03916-x","article-title":"Sepsis-induced cardiomyopathy: understanding pathophysiology and clinical implications","volume":"99","author":"Liu","year":"2025","journal-title":"Arch Toxicol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.chest.2025.08.013","article-title":"Sepsis-induced cardiomyopathy: mechanism, prevalence, assessment, prognosis, and management","volume":"168","author":"Sato","year":"2025","journal-title":"Chest"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1093\/eurheartj\/ehaf340","article-title":"Sepsis-induced cardiomyopathy","volume":"46","author":"Aissaoui","year":"2025","journal-title":"Eur Heart J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3892\/mmr.2023.13114","article-title":"Sepsis-induced cardiac dysfunction and pathogenetic mechanisms (review)","volume":"28","author":"Song","year":"2023","journal-title":"Mol Med Rep"},{"key":"B6","doi-asserted-by":"publisher","first-page":"109716","DOI":"10.1016\/j.intimp.2023.109716","article-title":"S100a8\/a9 contributes to sepsis-induced cardiomyopathy by activating ERK1\/2-Drp1-mediated mitochondrial fission and respiratory dysfunction","volume":"115","author":"Wu","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"115493","DOI":"10.1016\/j.biopha.2023.115493","article-title":"Role of toll-like receptor-mediated pyroptosis in sepsis-induced cardiomyopathy","volume":"167","author":"Fan","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"B8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3892\/ijmm.2023.5319","article-title":"Quercetin ameliorates ferroptosis of rat cardiomyocytes via activation of the SIRT1\/p53\/SLC7A11 signaling pathway to alleviate sepsis-induced cardiomyopathy","volume":"52","author":"Lin","year":"2023","journal-title":"Int J Mol Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"118952","DOI":"10.1016\/j.jep.2024.118952","article-title":"Po-Ge-Jiu-Xin decoction alleviate sepsis-induced cardiomyopathy via regulating phosphatase and tensin homolog-induced putative kinase 1\/parkin-mediated mitophagy","volume":"337","author":"Wang","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41569-020-00492-2","article-title":"Pathophysiology of sepsis-induced cardiomyopathy","volume":"18","author":"Hollenberg","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"122611","DOI":"10.1016\/j.lfs.2024.122611","article-title":"Melatonin: a potential protective multifaceted force for sepsis-induced cardiomyopathy","volume":"346","author":"Casper","year":"2024","journal-title":"Life Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.7150\/thno.103809","article-title":"The m6A modification of SOX18 leads to increased PTX3 and cardiomyocyte pyroptosis in sepsis-induced cardiomyopathy","volume":"15","author":"Sun","year":"2025","journal-title":"Theranostics"},{"key":"B13","doi-asserted-by":"publisher","first-page":"106473","DOI":"10.1016\/j.phrs.2022.106473","article-title":"Losartan attenuates sepsis-induced cardiomyopathy by regulating macrophage polarization via TLR4-mediated NF-\u03baB and MAPK signaling","volume":"185","author":"Chen","year":"2022","journal-title":"Pharmacol Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1161\/circresaha.124.325708","article-title":"Lactylation of HADHA promotes sepsis-induced myocardial depression","volume":"137","author":"Zhang","year":"2025","journal-title":"Circ Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1002\/jcsm.12763","article-title":"Inhibition of the NLRP3\/IL-1\u03b2 axis protects against sepsis-induced cardiomyopathy","volume":"12","author":"Busch","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1510232","DOI":"10.3389\/fcell.2024.1510232","article-title":"Ferrostatin-1 improves acute sepsis-induced cardiomyopathy via inhibiting neutrophil infiltration through impaired chemokine axis","volume":"12","author":"Li","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.freeradbiomed.2020.08.009","article-title":"Ferritinophagy-mediated ferroptosis is involved in sepsis-induced cardiac injury","volume":"160","author":"Li","year":"2020","journal-title":"Free Radical Biol Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"111374","DOI":"10.1016\/j.cellsig.2024.111374","article-title":"Erbin alleviates sepsis-induced cardiomyopathy by inhibiting RIPK1-dependent necroptosis through activating PKA\/CREB pathway","volume":"123","author":"Zhou","year":"2024","journal-title":"Cell Signal"},{"key":"B19","doi-asserted-by":"publisher","first-page":"4710","DOI":"10.3390\/ijms25094710","article-title":"Current perspectives of mitochondria in sepsis-induced cardiomyopathy","volume":"25","author":"Kuroshima","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"155175","DOI":"10.1016\/j.phymed.2023.155175","article-title":"Chicoric acid ameliorates sepsis-induced cardiomyopathy via regulating macrophage metabolism reprogramming","volume":"123","author":"Sun","year":"2024","journal-title":"Phytomedicine"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12967-022-03842-5","article-title":"Angiotensin-(1-7) ameliorates sepsis-induced cardiomyopathy by alleviating inflammatory response and mitochondrial damage through the NF-\u03baB and MAPK pathways","volume":"21","author":"Chen","year":"2023","journal-title":"J Transl Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s10565-024-09923-z","article-title":"Ace2 alleviates sepsis-induced cardiomyopathy through inhibiting M1 macrophage via NF-\u03baB\/STAT1 signals","volume":"40","author":"Xiao","year":"2024","journal-title":"Cell Biol Toxicol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10557-022-07354-8","article-title":"Therapeutic strategies targeting mitochondrial dysfunction in sepsis-induced cardiomyopathy","volume":"38","author":"Salami","year":"2024","journal-title":"Cardiovasc Drugs Ther"},{"key":"B24","doi-asserted-by":"publisher","first-page":"114245","DOI":"10.1016\/j.intimp.2025.114245","article-title":"Targeted inhibition of NEK7 preventing sepsis-induced cardiomyopathy by inhibiting NLRP3 inflammasome","volume":"151","author":"Wen","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jointm.2021.11.004","article-title":"Septic cardiomyopathy: diagnosis and management","volume":"2","author":"Boissier","year":"2022","journal-title":"J Intensive Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40560-024-00770-y","article-title":"Sepsis-induced cardiogenic shock: controversies and evidence gaps in diagnosis and management","volume":"13","author":"Sato","year":"2025","journal-title":"J Intensive Care"},{"key":"B27","first-page":"261","article-title":"Effects of acute L-carnitine intake on metabolic and blood lactate levels of elite badminton players","volume":"29","author":"Ero\u011flu","year":"2008","journal-title":"Neuro Endocrinol Lett"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e70559","DOI":"10.1111\/jcmm.70559","article-title":"Roles and therapeutic targeting of exosomes in sepsis-induced cardiomyopathy","volume":"29","author":"Fan","year":"2025","journal-title":"J Cell Mol Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"175745","DOI":"10.1016\/j.ejphar.2023.175745","article-title":"The protective effects of sophocarpine on sepsis-induced cardiomyopathy","volume":"950","author":"Fu","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e70027","DOI":"10.1002\/jcp.70027","article-title":"Pleiotropic role of TNIK in sepsis-induced cardiomyopathy","volume":"240","author":"Yang","year":"2025","journal-title":"J Cell Physiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s00011-024-01881-w","article-title":"Pld2 deletion ameliorates sepsis-induced cardiomyopathy by suppressing cardiomyocyte pyroptosis via the NLRP3\/caspase 1\/GSDMD pathway","volume":"73","author":"Li","year":"2024","journal-title":"Inflamm Res"},{"key":"B32","doi-asserted-by":"publisher","first-page":"109067","DOI":"10.1016\/j.intimp.2022.109067","article-title":"Omaveloxolone attenuates the sepsis-induced cardiomyopathy via activating the nuclear factor erythroid 2-related factor 2","volume":"111","author":"Jian","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s00011-025-02037-0","article-title":"Nrf2 mediated signaling axis in sepsis-induced cardiomyopathy: potential pharmacological receptor","volume":"74","author":"Wang","year":"2025","journal-title":"Inflamm Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3892\/mmr.2025.13483","article-title":"New developments in the role of ferroptosis in sepsis-induced cardiomyopathy (review)","volume":"31","author":"Wang","year":"2025","journal-title":"Mol Med Rep"},{"key":"B35","doi-asserted-by":"publisher","first-page":"S137","DOI":"10.1177\/09603271211033768","article-title":"MiR-141 attenuates sepsis-induced cardiomyopathy by targeting DAPK1","volume":"40","author":"Song","year":"2021","journal-title":"Hum Exp Toxicol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"118740","DOI":"10.1016\/j.jep.2024.118740","article-title":"In vivo and in vitro study on the regulatory mechanism of XiaoChaiHu decoction on PANoptosis in sepsis-induced cardiomyopathy","volume":"336","author":"Wang","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"166497","DOI":"10.1016\/j.bbadis.2022.166497","article-title":"Gyy4137 ameliorates sepsis-induced cardiomyopathy via NLRP3 pathway","volume":"1868","author":"Zhou","year":"2022","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41569-023-00837-7","article-title":"Cardiac-resident macrophages protect against sepsis-induced cardiomyopathy","volume":"20","author":"Lim","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"175930","DOI":"10.1016\/j.ejphar.2023.175930","article-title":"Dapagliflozin ameliorates sepsis-induced heart injury by inhibiting cardiomyocyte apoptosis and electrical remodeling through the PI3K\/Akt pathway","volume":"955","author":"Han","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.freeradbiomed.2024.02.026","article-title":"Cardiac resolvin D2 ameliorates sepsis-induced cardiomyopathy via inhibiting caspase-11\/GSDMD dependent pyroptosis","volume":"215","author":"Zhang","year":"2024","journal-title":"Free Radical Biol Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1590313","DOI":"10.3389\/fimmu.2025.1590313","article-title":"Advances in neutrophil extracellular traps and ferroptosis in sepsis-induced cardiomyopathy","volume":"16","author":"Zeng","year":"2025","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"110311","DOI":"10.1016\/j.intimp.2023.110311","article-title":"Tirzepatide attenuates lipopolysaccharide-induced left ventricular remodeling and dysfunction by inhibiting the TLR4\/NF-kB\/NLRP3 pathway","volume":"120","author":"Liu","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"834077","DOI":"10.3389\/fphys.2022.834077","article-title":"Rutin inhibits cardiac apoptosis and prevents sepsis-induced cardiomyopathy","volume":"13","author":"Meng","year":"2022","journal-title":"Front Physiol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"24483","DOI":"10.1038\/s41598-024-75480-4","article-title":"Prognostic value of red blood cell distribution width in sepsis induced cardiomyopathy patients","volume":"14","author":"Liao","year":"2024","journal-title":"Sci Rep"},{"key":"B45","doi-asserted-by":"publisher","first-page":"5627","DOI":"10.1111\/bph.70132","article-title":"Molecular hydrogen protects against sepsis-induced cardiomyopathy through improving Golgi stress-mediated autophagy, inflammation and apoptosis","volume":"182","author":"Meng","year":"2025","journal-title":"Br J Pharmacol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.yjmcc.2024.08.003","article-title":"Mechanisms of the septic heart: from inflammatory response to myocardial edema","volume":"195","author":"Fan","year":"2024","journal-title":"J Mol Cell Cardiol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"113511","DOI":"10.1016\/j.intimp.2024.113511","article-title":"Lymphatic vessels are necessary for cardiac function and inflammation resolution in sepsis-induced cardiomyopathy","volume":"143","author":"Wu","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"175451","DOI":"10.1016\/j.ejphar.2022.175451","article-title":"Jujuboside A attenuates sepsis-induced cardiomyopathy by inhibiting inflammation and regulating autophagy","volume":"947","author":"Wang","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s13755-025-00367-1","article-title":"An interpretable machine learning model for predicting sepsis-induced cardiomyopathy in ICU patients: development and validation using the MIMIC-IV database","volume":"13","author":"Sha","year":"2025","journal-title":"Health Inf Sci Syst"},{"key":"B50","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3390\/biom15020286","article-title":"Integrated omics insights into dapagliflozin effects in sepsis-induced cardiomyopathy","volume":"15","author":"Lai","year":"2025","journal-title":"Biomolecules"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1093\/infdis\/jiad365","article-title":"Inhibition of pyruvate dehydrogenase kinase 4 attenuates myocardial and mitochondrial injury in sepsis-induced cardiomyopathy","volume":"229","author":"Chen","year":"2024","journal-title":"J Infect Dis"},{"key":"B52","doi-asserted-by":"publisher","first-page":"112103","DOI":"10.1016\/j.intimp.2024.112103","article-title":"Inhibition of Golgi stress alleviates sepsis-induced cardiomyopathy by reducing inflammation and apoptosis","volume":"133","author":"Meng","year":"2024","journal-title":"Int Immunopharmacol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1825255\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T08:04:22Z","timestamp":1787213062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1825255\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":52,"alternative-id":["10.3389\/fcvm.2026.1825255"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1825255","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"article-number":"1825255"}}